Is Crinetics Pharmaceuticals Inc (CRNX) Stock at the Top of the Biotechnology Industry?

Crinetics Pharmaceuticals Inc (CRNX) is around the top of the Biotechnology industry according to InvestorsObserver. CRNX received an overall rating of 79, which means that it scores higher than 79 percent of all stocks. Crinetics Pharmaceuticals Inc also achieved a score of 98 in the Biotechnology industry, putting it above 98 percent of Biotechnology stocks. Biotechnology is ranked 60 out of the 148 industries.

CRNX has an Overall Score of 79. Find out what this means to you and get the rest of the rankings on CRNX!

See Full CRNX Report

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector. These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Crinetics Pharmaceuticals Inc Stock Today?

Crinetics Pharmaceuticals Inc (CRNX) stock is trading at $19.39 as of 3:46 PM on Thursday, Jun 9, a loss of -$0.50, or -2.49% from the previous closing price of $19.89. The stock has traded between $19.15 and $19.90 so far today. Volume today is less active than usual. So far 151,589 shares have traded compared to average volume of 348,947 shares. Click Here to get the full Stock Report for Crinetics Pharmaceuticals Inc stock.